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Samuel C. Yiu, PhD, MD a,b,c,⇑AbstractPurpose: To compare postoperative complications after Descemet stripping with automated endothelial keratoplasty (DSAEK) in
patients with and without glaucoma.
Methods: For this retrospective study a series of 298 DSAEK cases performed at the Doheny Eye Institute were taken, we com-
pared postoperative complications in eyes with glaucoma on medication (55) or with previous glaucoma surgeries (64) with a time-
matched group of all other DSAEK cases (179, control).
Results: With a mean follow-up of 1.85 ± 1.12 years, the complication rates were 12.8%, 11.1%, and 26.8% for postoperative graft
detachment, graft failure, and IOP elevation, respectively. Graft detachment was an independent risk factor for graft failure (odds
ratio OR = 12.35, 95% confidence interval CI [5.46–27.90], P < 0.001). Graft detachment was not associated with either history of
glaucoma or glaucoma surgery (P > 0.05). Glaucoma on medication had no increased risks of graft failure compared to normal
eyes (P = 0.38). However, increased risk of failure was seen in eyes with prior incisional glaucoma surgeries (OR = 4.26, 95% CI
[1.87–9.71], P < 0.001). Medically managed glaucoma has increased risks of postoperative IOP elevation (OR = 2.39, 95% CI
[1.25–4.57], P = 0.013), whereas surgically managed glaucoma has no significant elevation (P = 0.23). Elevation of IOP was not sig-
nificantly correlated with graft failure (P = 0.21).
Conclusion: DSAEK is the preferred treatment for corneal endothelial dystrophy. We observed that having glaucoma or glaucoma
surgery is not associated with graft detachment. A history of glaucoma surgery and postoperative graft detachment appeared to
be important risk factors for graft failure. And more studies are indicated to study long-term IOP evolution in post-DSAEK patients
and its association with graft survival.
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Endothelial keratoplasty (EK) has become the preferred
surgical remedy for corneal endothelial diseases, due to the
remarkably expeditious visual rehabilitation and favorable
complication profiles, compared to those achieved with pe-netrating keratoplasty (PKP).1–6 Among the repertoire of EK
procedures, Descemet stripping with automated endothelial
keratoplasty (DSAEK) emerges as the procedure of choice for
many corneal surgeons.7 Commonly reported postoperative
complications of DSAEK are graft detachment (1.5–82%), iat-
rogenic primary graft failure (0–45%), induced glaucoma (0–e:
al.com
, USA
74 P. Nguyen et al.15%), pupillary block (0–2%), and rarely, epithelial ingrowth
and retinal detachment.6,8–20 Most complications are related
to surgical technique, and recent surgical innovations effec-
tively reduce the incidence of complications.8,10,12,20–23
Despite its immense popularity, DSAEK is still a relatively
new procedure, and the effects of glaucoma or a history of
glaucoma surgery on postoperative complications have not
been fully investigated. The reportedly high rates of intraoc-
ular pressure (IOP) elevation after DSAEK are particularly
concerning, especially when the identified risk factors include
a history of ocular hypertension, preexisting glaucoma, or
previous glaucoma surgery.15,16,18 Another salient finding is
the association between preexisting glaucoma or steroid-
responsive ocular hypertension and the increased risk of graft
rejection.19 A similar correlation between glaucoma and PKP
graft failure has been reported.24
Given the risks of graft rejection and development of glau-
comatous optic neuropathy in DSAEK patients, it is essential
to characterize surgical outcomes in these patients. Accord-
ingly, we evaluated the incidence of graft detachment, graft
failure, and IOP elevation in three groups of DSAEK patients:
those with no history of glaucoma; those receiving medica-
tion(s) for glaucoma; and those with a history of glaucoma
procedures. Subsequently, we compared the long-term
course of IOP changes in these groups.Methods
This retrospective study included all patients who under-
went DSAEK for corneal endothelial failure at the Doheny
Eye Institute; all surgeries were performed by the corneal
specialists (SCY, JCS, MH). A total of 316 DSAEK cases, trea-
ted from April 2006 to August 2010, were evaluated in this
study. All preoperative evaluations and DSAEK procedures
were performed at the Doheny Eye Institute. The study was
approved by the Institutional Review Board at the University
of Southern California and was in accordance with the tenets
set forth in the Declaration of Helsinki. All procedures and
data management conformed to the Health Insurance Porta-
bility and Accountability Act of 1996.
Classification
Patients were classified as the medical glaucoma (MG)
group if they met any of the following criteria: a documented
history of glaucoma, preoperative use of ocular antihyperten-
sive medications, or evidence of glaucomatous optic neurop-
athy on preoperative evaluation or on subsequent
examination if the initial view was suboptimal. The presence
of a narrow angle or a history of prophylactic laser iridotomy
was not classified as medical glaucoma unless the aforemen-
tioned criteria were met. A history of glaucoma filtering pro-
cedure and/or glaucoma drainage device implant was the
inclusion criterion for classification as surgical glaucoma
(SG). The remaining patients were designated non-glaucoma
(N).
IOP elevation
The study criteria for postoperative IOP elevation were
IOPP 24 mmHg or a relative increaseP 10 mmHg from pre-
operative value. The criteria were selected for consistencywith prior studies.15,25 At any subsequent visit, IOP measure-
ments which satisfied the study criteria would be categorized
as postoperative IOP elevation. The IOP measurements were
obtained by either a trained ophthalmic technician or an oph-
thalmologist using a calibrated TonoPen XL tonometer
(Medtronics, Jacksonville, FL). Only readings with a confi-
dence limit of 5% were used. Average of three measurements
was recorded.
Graft detachment or graft failure
Terry and colleagues9 defined posterior graft dislocation
as complete separation of the donor tissue from the recipient
bed by a layer of interfacial fluid, requiring postoperative
intervention. In contrast, Suh et al.13 described detachment
as partial or complete detachment or dislocation, regardless
of whether patients required postoperative surgical interven-
tion. Since DSAEK may be more technically challenging in
eyes with prior surgery, particularly glaucoma drainage de-
vice placement, we defined graft detachment to include
any interfacial separation, which may or may not require post-
operative surgical intervention. Similarly, we expanded graft
failure to include persistent corneal edema lasting longer
than 6 weeks after transplantation, including failure after dis-
location or detachment, despite proper apposition of the
DSAEK lenticule.
Statistical analysis
Statistical analyses were performed by GraphPad InStat
version 3.05 for Windows (GraphPad Software, San Diego,
CA; www.graphpad.com). Descriptive statistics were re-
ported as mean ± standard deviation, unless otherwise sta-
ted. We defined statistical significance at P-values < 0.05.
The odds ratios (OR)) of complications, 95% confidence inter-
val (95% CI), and P values were calculated using the two-
tailed Fisher exact test. We excluded patients having less
than 90-day follow-up. Mean IOP values were compared
using the one-way ANOVA tests because the data followed
a Gaussian distribution according to the method of Kolmogo-
rov and Smirnov.Results
Of the 316 transplants reviewed, 18 were excluded be-
cause of inadequate follow-up (<90 days); a total of 298 were
included for analysis. Mean follow-up period was
1.85 ± 1.12 years, with a range of 90–1649 days. The overall
mean patient age was 74.0 ± 11.8 years (range = 28–
97 years). The age breakdown for the three groups, non-
glaucoma (N), medical glaucoma (MG), and surgical glau-
coma (SG), was 75.3 ± 10.8, 72.4 ± 10.7, and
73.1 ± 14.8 years, respectively. Females constituted 60.7%
of the overall group. The most common medical comorbidity
was hypertension, followed by diabetes and arthritis. Many of
our patients had ocular comorbidities that contributed to
poor visual rehabilitation Table 1. The complexity of the past
medical and ocular histories of our patients reflected the fact
that our institute is a tertiary referral center.
229 (76.8%) had undergone prior intraocular surgery,
including cataract extraction (212 or 71.1%). Accordingly,
pseudophakic bullous keratopathy (PBK) accounted for a
Table 1. Demographics.
Medical comorbidity % of
patients
Hypertension 45.8
Arthritis 18.3
Diabetes 17.6
Cardiac diseases 15.3
Dyslipidemia 5.0
Thyroid disease 3.8
Malignancies 3.4
Asthma 2.3
Ocular comorbidity
Glaucoma 40
Diabetic retinopathy 8.4
Age-related macular degeneration 5.7
Epiretinal membrane 3.1
Cystoid macular edema 4.6
History of retinal detachment 3.4
History of retinal vein occlusion 0.8
Band keratopathy 1.1
Giant cell arteritis 0.4
Amblyopia 1.5
Wet AMD 1.1
Past ocular surgery
Cataract extraction/intraocular lens insertion (CE/IOL)
only
41.6
CE/IOL & glaucoma surgery 13.1
CE/IOL & corneal surgery 6.7
CE/IOL & vitreoretinal surgery 4.0
Corneal surgery 2.0
Vitreoretinal surgery 0.0
Glaucoma surgery 0.7
Three or more types of intraocular surgeries 8.7
Diagnosis of corneal edema
PBK 41.9
FED 22.8
FED + PBK 16.8
Failed DSEK 8.1
Failed PK 3.7
APK 1.0
Corneal decompensation 5.7
Note: Findings are for ipsilateral eye. Here, vitreoretinal surgery was defined as
intraocular vitreoretinal surgery; cryocoagulation, photocoagulation, or intravitreal
injections were excluded. Similarly, intraocular glaucoma surgery encompassed glau-
coma drainage device implant or trabeculectomy; laser iridotomy or trabeculoplasty
were excluded. DSEK: Descemet’s stripping and endothelial keratoplasty; PKP:
penetrating keratoplasty; FED: Fuchs endothelial dystrophy; PBK: pseudophakic bul-
lous keratopathy; APK: aphakic keratopathy.
Figure 1. Complication distribution among the normal (N)
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endothelial dystrophy (FED, 68 or 22.8%), combined FED
and PBK (50 or 16.8%), and others Table 1. Forty percent
of the recipients (119) had preexisting glaucoma; of those,
55 were only on medication with no prior incisional glaucoma
surgery (MG group) and 64 had prior incisional glaucoma sur-
geries (SG group). The SG group was composed of 18 eyes
with history of trabeculectomy and mitomycin C, 35 eyes with
glaucoma drainage device placements, and 11 eyes with
both. 179 eyes with no history of glaucoma comprised the
N group.
The overall rates of complication were as follows: graft
detachment (12.8%), graft failure (11.1%), and IOP elevation
(26.8%). Forty eyes had graft detachment, and 40% of these
detachments (18/40) progressed to develop graft failure de-
spite refloating and/or suture placement, ultimately requiring
repeat DSAEK (12) and PKP (6). Twenty grafts (20/40) re-
mained clear after refloating and/or suture placement. Two
detachments (2/40) spontaneously reattached.
As expected, graft detachment was associated with a sig-
nificant risk of graft failure (OR = 12.35, 95% CI [5.46–27.90],
P < 0.0001). Detachment rate was highest in patients who
have had prior incisional glaucoma surgeries (18.2%), fol-
lowed by patients who were only on ocular antihypertensive
eyedrops (12.7%), and lowest in non-glaucoma patients
(11.1%), Fig. 1. Within the SG group, 3/18 patients with prior
trabeculectomy/MMC, 6/35 of patients with only glaucoma
drainage device implants, and 2/11 of patients with both tra-
beculectomy/MMC and glaucoma drainage implant place-
ments had detachment Fig. 1. Compared to group N,
however, the association was not statistically significant
(P > 0.05).
Over this follow-up period, the overall incidence of IOP
elevation in this series was 80 eyes (26.8%). Incidence of
IOP elevation was highest in the MG group (22/55, 40%), fol-
lowed by SG (19/64, 29.7%) and N groups (39/179, 21.8%).
12/80 (15%) of the eyes with IOP elevation developed graft
failure compared to 21/221 (9.5%) with normal IOP. This cor-
relation did not reach statistical significance (OR = 1.42, 95%
CI [0.86–2.33], P = 0.21). Here, postoperative IOP elevation
was associated with the MG (OR = 2.39, 95% CI [1.25–4.57],
P = 0.013), but not the SG group (OR = 1.52, 95% CI [0.80–, medical glaucoma (MG) and surgical glaucoma (SG).
76 P. Nguyen et al.2.88], P = 0.23). We did not discern a significant correlation
between IOP elevation and graft failure.
Having prior incisional glaucoma surgery appeared to in-
crease the risks of graft failure (OR = 4.26, 95%CI [1.87–
9.81], P < 0.001). Breaking down SG into subgroups sug-
gested that having both glaucoma filtering procedure and
glaucoma drainage device implant had the highest risk
(OR = 5.22, P = 0.045), followed by drainage device implant
only (OR = 4.82, P = 0.002); filtering procedure had non-sig-
nificant risk (OR = 2.78, P = 0.14). In contrast, no increased
risk of failure was observed in the MG group (P = 0.38).
Risk analysis substantiated the increased risk of graft fail-
ure in patients with a priori glaucoma. Cumulatively, DSAEK
recipients with glaucoma had a higher risk of graft failure
compared to those without glaucoma, (OR = 2.98, 95% CI
[1.41–6.33], and P = 0.004). This risk increased further in the
group SG, compared to group N with no a priori diagnosis
of glaucoma (OR = 4.26, 95% CI [1.87–9.71], P < 0.001).
Breaking down SG into subgroups suggested that having
both glaucoma filtering procedure and glaucoma drainage
device implant had the highest risk (OR = 5.22, P = 0.045),
followed by drainage device implant only (OR = 4.82,
P = 0.002); filtering procedure had non-significant risk
(OR = 2.78, P = 0.14). In contrast, no increased risk of failure
was observed in the MG group (P = 0.38).
Discussion
Descemet stripping with endothelial keratoplasty has be-
come the surgical modality of choice for management of
endothelial disorders because of its excellent visual out-
comes and favorable complication profiles compared to
PKP. Five-year data from Price et al.26 showed similar cumu-
lative 5-year survival rates between DSAEK and full-thickness
corneal transplant for FED (95% vs. 93%) and pseudophakic
or aphakic corneal edema (76% vs. 73%). Innovations in surgi-
cal techniques continue to improve surgical outcomes and
patient satisfaction.10,12,20–23 Concerns remain, however,
regarding graft failure and post-endothelial keratoplasty
glaucoma. This retrospective study aimed to offer insights
into these postoperative complications and recipient
predispositions.
Recent data from a smaller series also found no statistical
significance between the detachment rate in the surgical
glaucoma and control groups (22.2 vs. 24.1%, Aldave A, Yu
F, 2009 Annual Meeting of the American Association of Cat-
aract and Refractive Surgery, unpublished data). These con-
clusions were corroborated by Phillips et al.27 and Shah
et al.,28 although their rates were much lower than in the
present series. Our definition of detachment was similar to
that of Suh et al.,13 which was more inclusive than that of Ter-
ry and colleagues; Suh et al reported a detachment rate of
23%. We found an overall detachment rate of 12.8%. Simi-
larly, our analyses showed no significant correlation between
prior incisional glaucoma procedures and DSAEK graft
detachment.
Since DSAEK is an emerging and widely adopted proce-
dure, the true incidence of induced glaucoma after DSAEK
has not been clearly established. Earlier reports suggested
an incidence of zero to 18%.17 Vajaranant et al.15 reported
a relatively high incidence of IOP elevation after DSAEK in
35% of patients with no prior glaucoma, 45% of patients withprior glaucoma, and 43% of patients with preexisting glau-
coma surgery. Lee et al.14 reported an IOP rise to greater
than 30 mmHg during the first 6 months following DSAEK
surgery in 13%. The importance of post-endothelial keratopl-
asty glaucoma cannot be overemphasized; unfortunately,
preoperative assessment of glaucoma in undiagnosed pa-
tients is a difficult task, especially at a tertiary referral center.
Comparison of pre- and postoperative optic nerve findings
and visual field progression may be hindered by media opac-
ity at presentation or by the decision of some patients to re-
turn to their referring physician after receiving surgery. For
PKP, IOP elevation, with or without associated visual field loss
or changes of the optic nerve, continues to be a commonly
used indicator of postkeratoplasty glaucoma; yet the criteria
for IOP elevation has been inconsistent in the literature.15,29–31
Here, our study criteria were similar to those defined by Vaj-
aranant et al.:15 postoperative IOP elevation where
IOPP 24 mmHg or relative increaseP 10 mmHg in IOP
from preoperative value. We found that 26.7% of the cohort
met these criteria for IOP elevation over a mean follow-up of
1.85 years. Interestingly, we noted that medically managed
glaucoma patients had the highest incidence of IOP elevation
and up to 22% of patients with no previous diagnosis of glau-
coma also had IOP elevation. These numbers were slightly
lower than those reported by Vajaranant et al.15 The disparity
may be due in part to different patient constituency in the
two studies (16% vs. 18.5% in the MG group and 5% vs.
21.5% in the SG group). The patients in their series predom-
inantly had FED. A larger proportion (71.1%) of our series was
pseudophakic. Proposed mechanisms for post-DSAEK glau-
coma include pupillary block, closed angle from peripheral
anterior synechiae, distortion of angle from long or tight su-
ture, and steroid response.14,15,17,32 The observation that IOP
elevation began near postop month one in the MG group
lends some evidence to hypothesis of steroid response con-
tribution in post-DSAEK glaucoma.
It is difficult to isolate each factor as an individual risk for
graft failure; undoubtedly, the causality is multifactorial. In
our series, graft detachment appeared to be the most signif-
icant contributor to graft failure (P-value < 0.001). Accord-
ingly, an effective way to further reduce the risk of graft
failure is continued innovations of surgical techniques to min-
imize graft detachment.10,12,20–23
Glaucoma has been documented in the PKP literature24 as
a significant risk factor for graft failure and, more recently,
has been proposed as a risk factor for DSAEK19 as well. Over-
all, we found that IOP elevation by itself may not increase the
risk (P > 0.05); however, having had a history of glaucoma,
particularly glaucoma drainage device implant, significantly
increases predisposition to failure (P < 0.001). Our findings
corroborate data from the literature. Price et al.19,26 reported
a 5-year survival rate of 40% in patients with prior glaucoma
shunt or trabeculectomy surgery compared to 95% of those
without, and the hazard ratio was calculated to be 2. This
trend was also observed in PKP patients where pseudopha-
kia, aphakia, and prior glaucoma surgery substantially in-
creased the risks of graft failure.24,33 Recently, Hollander
et al.34 reported a 3-year failure rate of 59.1% in PKP patients
with Ahmed valves. Our data suggest that preexisting glau-
coma is associated with graft failure.
The findings that medically treated glaucoma was associ-
ated with increased IOP but not graft failure, whereas surgi-
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not increased IOP, maybe consistent with the existing litera-
ture suggesting possible post-GDI breach in blood–aqueous
barrier or chronic trauma producing elevated levels of aque-
ous humor oxidative and inflammatory products that may
precipitate corneal endothelial damage.35 Given that DSAEK
patients have a higher incidence of prior glaucoma shunt and
trabeculectomy surgeries compared to PKP in a series by
Price et al.,26 more investigations are recommended to eluci-
date the mechanism, natural progression, and methods to
improve outcome, either by further innovation in surgical
techniques or by optimization of pre- and postoperative
management.
Caution is needed when interpreting these findings, as the
many limitations inherent in a retrospective study were
clearly recognized here and may prevent generalization of
our results. This series captured cumulative data over a mean
follow-up period of 2 years, which is both an advantage and
disadvantage. It allows inclusion of a larger database. How-
ever, the heterogeneous patient population may confound
the analysis; and the evolution of surgical techniques among
the four corneal surgeons may have influence on the surgical
outcomes. We acknowledge that IOP measurement using
Tonopen is an important flaw, as it has been reported to pro-
vide inadequate measurement for the management of glau-
coma and ocular hypertension.36,37 In this series, the
Tonopen measurement was only used as a screening param-
eter and not for IOP management. Nevertheless, the results
of this series add to a growing body of literature that aims
to address the long-term IOP management in DSAEK pa-
tients. The association between graft failure and history of
glaucoma surgery, as well as the high incidence of postoper-
ative IOP elevation in this series and others, should prompt
the surgeon to focus on preoperative risk assessment and
postoperative management to reduce the risks of graft fail-
ure and glaucoma.
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